Last reviewed · How we verify

NCT05425394

A Study of Effects of Delay in the First Bathing Time of Body Temperature and the Rate of Exclusive Breastfeeding

Completed NA Last updated 21 June 2022
What this trial tests

NA trial testing Delay first bath in Newborn Hypothermia in 90 participants. Completed in 25 January 2022.

Timeline
2 September 2021
Primary endpoint
25 January 2022
25 January 2022

Quick facts

Lead sponsorCardinal Tien Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment90
Start date2 September 2021
Primary completion25 January 2022
Estimated completion25 January 2022
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

Cardinal Tien Hospital

Who can join

Eligibility, any sex, with Newborn Hypothermia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Using delaying the first bathing by 8 hours as an interventional measure, considering the consistent effect of physiological maturity, newborns with a gestational age of ≥37 weeks were selected as the subjects in the nursery cases, and randomly assigned to the delayed bathing group and the routine bathing group , 10 minutes before bathing, immediately after bathing, 10 minutes, 30 minutes, and 60 minutes to analyze the differences in body temperature of the cases, and the differences in the rate of exclusive breastfeeding at discharge.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Cardinal Tien Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05425394.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing